Stocks to sell

For the quarter ending May 1, 2021, GameStop (NYSE:GME) was able to reduce its total store count by 12% year-over-year (YoY), according to its first-quarter earnings release. As a result, the company’s losses fell from $165.1 million or $2.65 per share last year to just $66.8 million or $1.01 per share this quarter. This is

The U.S. infrastructure bill has been passed by the Senate. Will this initiative give ChargePoint (NYSE:CHPT) stock a boost? I wouldn’t really count on it. Sure, EV charging companies, including ChargePoint, stand to benefit greatly from this bill. The legislation could give early-stage companies in this industry a shot in the arm as they grow into

I have always wondered about why the memesters decided they liked Clover Health (NASDAQ:CLOV) stock. Source: Shutterstock Maybe it was the short squeeze, which came after Hindenburg Research issued a February report calling the business broken. Maybe it was Chamath Palihapitiya, whom I have likened to Prof. Harold Hill of The Music Man. (Full disclosure:

Exela Technologies (NASDAQ:XELA) is a Texas company that sells itself as a leader in business process automation. The XELA stock price is down 8.6% in the last six months. Source: Alextype/Shutterstock.com The current company is the result of a 2017 tie-up of three companies which now suffers from crushing debts. Exela is still around thanks to

“The pill that moves the needle.” This is the statement highlighted on Vaxart’s (NASDAQ:VXRT) website, and it is written to make a bold impression. Recently, the company has been in the spotlight for its Covid-19 vaccine that is notably in pill form. Its inoculation isn’t ready yet, but some investors have already picked up shares

It hasn’t been a fun ride for Workhorse (NASDAQ:WHKS) stock. Source: rblfmr / Shutterstock.com In fact, most start-up EV, low-quality special purpose acquisition companies (SPACs) and high-growth stocks have struggled over the past few months. In the case of WKHS stock, shares remain 76% below the all-time high set in February. Unfortunately for Workhorse, earnings aren’t

Clover Health Investments (NASDAQ:CLOV) recently reported second quarter revenue and earnings on Aug 11. The numbers showed a huge gain in revenue but an equally huge increase in its losses. This does not bode well for CLOV stock. Source: Shutterstock Additionally, Clover significantly raised its total 2021 revenue outlook from $820 million at the midpoint last quarter

When Clover Health (NASDAQ:CLOV) tested multiple bottoms from March to May, it set up a technical June rally next. Hindsight is 20/20 and does not make money. Speculators now know the CLOV stock spike from $8 to $28.85 in June would not last. Source: Shutterstock Bears are not done betting against Clover. The short float

Contrary to the belief of many commentators, I think that the outlook of Carnival Corporation (NYSE:CCL) stock has improved in recent weeks. Source: Ruth Peterkin / Shutterstock.com Despite the negative impact of the Delta variant of the novel coronavirus, other, positive factors or Carnival, are, for now, outweighing the latest outbreak. Still, I believe that

Talk of Clover Health (NASDAQ:CLOV) stock being a great short-squeeze play is making the rounds once again. Source: Shutterstock So, should you buy into the insuretech play now at around $8.50 per share, in anticipation of it zooming back to $20 per share and beyond? Not so fast. It may still be one of the

Seemingly out of nowhere, presidential and mayoral candidate Andrew Yang brought to the mainstream several ideas that absolutely needed to be talked about, one of them being data as the current century’s gold or oil. Since data is so valuable, it can theoretically fund multiple initiatives. For Palantir Technologies (NYSE:PLTR), that sounds just about right.

I have written two articles about Ocugen (NASDAQ:OCGN) in the past and I must say that if I had to summarize OCGN stock in two words, they would be irrational exuberance. Source: shutterstock.com/PhotobyTawat As of August 9, 2021, the company has a market valuation of $1.61 billion with zero revenue for 2019 and 2018. Yahoo!

Marin Software (NASDAQ:MRIN), which makes enterprise software for the advertising industry, cratered over the last month. I think it is likely to still drop further. MRIN stock closed at $14.45 on July 12 when I wrote that it was likely to drop much further. At the close on Aug. 12, it was at $5.67 and

Senseonics Holdings (NYSEAMERICAN:SENS) develops medical technology, including “continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa.” The company’s product line includes implantable CGM systems that go under the user’s skin and a removable, rechargeable transmitter that works with an app made by the company. SENS

Investors would be wise to follow the same advice regarding the big four airlines that emerged early in the pandemic. Unfortunately, for United Airlines (NASDAQ:UAL) stock that means investors should avoid it.  Source: NextNewMedia / Shutterstock.com The early narrative that emerged at the onset of the pandemic was that among the big four U.S. airlines

With cryptos bouncing back, mining plays like SOS Limited (NYSE:SOS) stock are coming back into the spotlight. But are shares in the China-based crypto mining company the way to play a possible continued recovery for Bitcoin (CCC:BTC-USD)? Not so fast. Source: biggunsband / Shutterstock.com Even before the crypto meltdown in May, SOS appeared to be

Since its reverse merger with Torchlight Energy Resources in June, the shares of Meta Materials (NASDAQ:MMAT) have taken a big hit. MMAT stock has tumbled 18% in the last month, despite generating a lot of social media chatter. Source: BLAGORODEZ / Shutterstock.com The company has lofty goals, but it currently has no proven products. That

Chinese stocks that ended up being targeted by Beijing have been pummeled in recent weeks. But after China’s government tried to reassure companies and investors that it was not trying to decimate the country’s stocks, some on Wall Street seem to believe that the government was giving the “all-clear” sign. But I don’t think that’s

The stock market has been incredibly volatile in the past couple of months. Investors are anxious about a marked increase in Covid-19 cases due to the latest Delta variant. The variant has become a dominant strain even in countries with high vaccination rates. Moreover, the recent disappointing jobs data has also led to a slowdown

Robinhood Markets (NASDAQ:HOOD) which just went public on Aug. 2, is unprofitable and not likely to see any net income until next year. The market might not exactly know this, especially since HOOD stock has risen over $20 since going public on July 29, closing at $34.82 on its first day. Source: mundissima / Shutterstock.com